Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Devalingam Mahalingam

Showing results (71-80 of 103) with videos related to

Pageof 11
Sort By:
Cancer Prevention Research (Philadelphia, Pa.)|March 31, 2016
Metformin for Reducing Racial/Ethnic Difference in Prostate Cancer Incidence for Men with Type II DiabetesChen-Pin Wang, Donna M Lehman, Yui-Wing F Lam, et al.
European Journal of Cancer (Oxford, England : 1990)|May 4, 2020
Randomised phase II trial of gemcitabine and nab-paclitaxel with necuparanib or placebo in untreated metastatic pancreas ductal adenocarcinomaEileen M O'Reilly, Diletta Barone, Devalingam Mahalingam, et al.
Oncotarget|October 27, 2016
TGF-β signal rewiring sustains epithelial-mesenchymal transition of circulating tumor cells in prostate cancer xenograft hostsGuangcun Huang, Pawel A Osmulski, Hakim Bouamar, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|December 24, 2009
Vorinostat enhances the activity of temsirolimus in renal cell carcinoma through suppression of survivin levelsDevalingam Mahalingam, Ernest C Medina, Juan A Esquivel, et al.
The Journal of Clinical Endocrinology and Metabolism|July 6, 2019
Nivolumab in Metastatic Adrenocortical Carcinoma: Results of a Phase 2 TrialBenedito A Carneiro, Bhavana Konda, Rubens B Costa, et al.
Journal of Clinical Pathology|May 25, 2011
A prospective randomised study of a rotary powered device (OnControl) for bone marrow aspiration and biopsyRonan T Swords, Javier Anguita, Russell A Higgins, et al.
HPB : the Official Journal of the International Hepato Pancreato Biliary Association|February 21, 2024
Safety and feasibility of establishing an adjuvant hepatic artery infusion programLauren M Janczewski, Rachel H Joung, Amir A Borhani, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|March 13, 2015
CD44 Isoform Status Predicts Response to Treatment with Anti-CD44 Antibody in Cancer PatientsFabian Birzele, Edgar Voss, Adam Nopora, et al.
The Prostate|January 3, 2013
Single-cell analysis of circulating tumor cells identifies cumulative expression patterns of EMT-related genes in metastatic prostate cancerChun-Liang Chen, Devalingam Mahalingam, Pawel Osmulski, et al.
Tomography (Ann Arbor, Mich.)|March 26, 2025
Delta Radiomics and Tumor Size: A New Predictive Radiomics Model for Chemotherapy Response in Liver Metastases from Breast and Colorectal CancerNicolò Gennaro, Moataz Soliman, Amir A Borhani, et al.
Pageof 11

Showing results (71-80 of 103) with videos related to

Sort By:
Pageof 11
Cancer Prevention Research (Philadelphia, Pa.)|March 31, 2016
Metformin for Reducing Racial/Ethnic Difference in Prostate Cancer Incidence for Men with Type II DiabetesChen-Pin Wang, Donna M Lehman, Yui-Wing F Lam, et al.
European Journal of Cancer (Oxford, England : 1990)|May 4, 2020
Randomised phase II trial of gemcitabine and nab-paclitaxel with necuparanib or placebo in untreated metastatic pancreas ductal adenocarcinomaEileen M O'Reilly, Diletta Barone, Devalingam Mahalingam, et al.
Oncotarget|October 27, 2016
TGF-β signal rewiring sustains epithelial-mesenchymal transition of circulating tumor cells in prostate cancer xenograft hostsGuangcun Huang, Pawel A Osmulski, Hakim Bouamar, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|December 24, 2009
Vorinostat enhances the activity of temsirolimus in renal cell carcinoma through suppression of survivin levelsDevalingam Mahalingam, Ernest C Medina, Juan A Esquivel, et al.
The Journal of Clinical Endocrinology and Metabolism|July 6, 2019
Nivolumab in Metastatic Adrenocortical Carcinoma: Results of a Phase 2 TrialBenedito A Carneiro, Bhavana Konda, Rubens B Costa, et al.
Journal of Clinical Pathology|May 25, 2011
A prospective randomised study of a rotary powered device (OnControl) for bone marrow aspiration and biopsyRonan T Swords, Javier Anguita, Russell A Higgins, et al.
HPB : the Official Journal of the International Hepato Pancreato Biliary Association|February 21, 2024
Safety and feasibility of establishing an adjuvant hepatic artery infusion programLauren M Janczewski, Rachel H Joung, Amir A Borhani, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|March 13, 2015
CD44 Isoform Status Predicts Response to Treatment with Anti-CD44 Antibody in Cancer PatientsFabian Birzele, Edgar Voss, Adam Nopora, et al.
The Prostate|January 3, 2013
Single-cell analysis of circulating tumor cells identifies cumulative expression patterns of EMT-related genes in metastatic prostate cancerChun-Liang Chen, Devalingam Mahalingam, Pawel Osmulski, et al.
Tomography (Ann Arbor, Mich.)|March 26, 2025
Delta Radiomics and Tumor Size: A New Predictive Radiomics Model for Chemotherapy Response in Liver Metastases from Breast and Colorectal CancerNicolò Gennaro, Moataz Soliman, Amir A Borhani, et al.
Pageof 11